Table: begin end state 1 18 cytoplasmic 19 37 transmembrane 38 43 non-cytoplasmic 44 61 transmembrane 62 72 cytoplasmic 73 91 transmembrane 92 102 non-cytoplasmic 103 119 transmembrane 120 125 cytoplasmic 126 143 transmembrane 144 177 non-cytoplasmic 178 199 transmembrane 200 276 cytoplasmic 277 287 transmembrane 288 296 cytoplasmic 297 318 transmembrane 319 341 non-cytoplasmic 342 361 transmembrane 362 367 cytoplasmic 368 388 transmembrane 389 393 non-cytoplasmic 394 427 transmembrane 428 446 cytoplasmic 447 506 transmembrane 507 511 cytoplasmic 512 532 transmembrane 533 536 non-cytoplasmic 537 560 transmembrane 561 567 cytoplasmic 568 589 transmembrane 590 599 non-cytoplasmic 600 623 transmembrane 624 631 cytoplasmic 632 669 transmembrane 670 670 non-cytoplasmic 671 678 cytoplasmic
Input: >WP_011765650.1 NCBI__GCF_000061505.1:WP_011765650.1 MTTSVSEPLAAGGRTMLRVVFWAAIAFSTFQIVTSAFSPLSSTVVRALHVGFLLLLTFLL FPLRGGEGKPTHLLTKLIGFAALGLACYHWLFEADLVQRAGELTTADMAVGIVTLVLVFE AARRIMGLALPLICLGFLAYALFGEHLPGAFAHRGYGLDQVIGQLAFGTEGIYGTPTYVS SSYIFLFILFGAFLEQAGMIQLFTDFSLGTVGHTKGGPAKVAVVSSGLMGTINGSGVANV VTTGQFTIPLMKRFGYQPAFAGAVEATSSMGGQIMPPVMGAVAFIMAETINVPYVEIAKA AAIPALLYFFTVFWMVHLEAGKRGLVGLPKAECPDPWAALKARWFLLLPLIALVYLLFAG FTPMFSGMVGLALTVVLIFGSAVAGWLNGTSLRLLFWIALGLACSAFAKVGIVSVMAAIA VLVVLLLPRRDGRATLALAVRALVDGALHALPVGVACALVGVIIGSLTLTGGATAFAGYI IQLGGHSMFLSLVLTMLTCLVLGMGIPTIPNYIITSSIAAPALLELGVPLIVSHMFVFYF GIMADLTPPVALAAFAAAPIAKTSGLRIGIRAVQIAAAGFVVPYMAVYAPELMLQGDKGL AATLYVVFKAALAVLLWGSTVIGHFRSPMNLVERALAFIAAALLVIAAPITDELGFLLAA AVIGGHLWRARRMAPVTL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server